Search > Skin Cancer
My employer runs this trial

IDP-001 for Cancer

II
Overseen ByInduPro Inc.
Age: 18+
Sex: Any
Trial Phase: Phase 1 & 2
Sponsor: InduPro, Inc.
Disqualifiers: Cardiac disease, Corneal disorder, Autoimmune, others
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutaneous).

Are You a Good Fit for This Trial?

This trial is for adults with advanced or metastatic solid tumors, such as certain lung, head and neck, esophageal, cervical, anal, or skin cancers. Participants must be in good physical condition (ECOG 0-1), have measurable disease, adequate organ function, a life expectancy over 12 weeks, and agree to use contraception.

Inclusion Criteria

* Agree to contraception requirements as outlined in the protocol
* Life expectancy greater than 12 weeks
I have tumors that can be measured by scans or exams.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Phase 1 Part 1 Dose Escalation

Participants with advanced or metastatic solid tumors will receive IDP-001 as intravenous (IV) infusion

8-12 weeks

Phase 1 Part 2 Indication Selection

Participants with a single tumor indication will receive IDP-001 as IV infusion

8-12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4-8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • IDP-001

Trial Overview

The study is testing a new drug called IDP-001 to see if it is safe and how well it works against various advanced or spreading squamous cell cancers. Researchers will monitor side effects and early signs of effectiveness.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Phase 1 Part 2 Indication SelectionExperimental Treatment1 Intervention
Group II: Phase 1 Part 1 Dose EscalationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

InduPro, Inc.

Lead Sponsor

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.